Cargando…
Phakic anterior chamber intraocular lens (Verisyse(™)) implantation in children for treatment of severe ansiometropia myopia and amblyopia: Six-month pilot clincial trial and review of literature
PURPOSE: The current study aims to evaluate both safety and efficacy of Verisyse(™) (AMO, Irvine, CA) phakic anterior chamber intraocular lens (IOL) in the reduction of clinically significant (>−8 D) myopic anisometropia in children who are noncompliant to traditional medical treatment including...
Autores principales: | Pirouzian, Amir, Ip, Kenneth C, O’Halloran, Henry S |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2709036/ https://www.ncbi.nlm.nih.gov/pubmed/19668592 |
Ejemplares similares
-
Choroidal Neovascularization Following Implantation of Verisyse™ Iris-Supported Phakic Intraocular Lens in a Pregnant Myopic Patient
por: Betts, Brent S, et al.
Publicado: (2012) -
Changes in anterior chamber volume after implantation of posterior chamber phakic intraocular lens in high myopia
por: Zhu, Yi, et al.
Publicado: (2018) -
Incidence rate and occurrence of visually significant cataract formation and corneal decompensation after implantation of Verisyse/Artisan phakic intraocular lens
por: Moshirfar, Majid, et al.
Publicado: (2014) -
Early Results with a New Posterior Chamber Phakic Intraocular Lens in Patients with High Myopia
por: Yaşa, Dilek, et al.
Publicado: (2018) -
Refractive Outcomes of Posterior Chamber Phakic Intraocular Lens Implantation for Correction of Myopia and Myopic Astigmatism
por: Pjano, Melisa Ahmedbegovic, et al.
Publicado: (2017)